DEF 14AThe Ballot
Janux Therapeutics, Inc. files DEF 14A
Filed Apr 28, 2026 · 2mo ago · Accession 0001193125-26-187095
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Janux Therapeutics, Inc.
- Ticker
- JANX
- CIK
- 1817713
- Form type
- DEF 14A
- Filing date
- Apr 28, 2026
- Report date
- Jun 11, 2026
- Document
- janx-20260428.htm
- Size
- 6.2 MB